Brian Schurko, MD
Hand Surgery · Burlington, MANPI 1407237910
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Axogen at 31.9% of the total. Reporting peaked in 2019 at $1,407 and has fallen 89.4% since, to $149 in 2025.
Across 35 payments — averaging $117.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$1K
- Kairos Surgical Inc$775
- Stryker$735
- Medical Device Business Services, Inc.$549
- Acumed LLC$475
- Arthrex$258
- plus $18 from 1 others
What the payments were for
- Travel & lodging$1,47836%
- Food & beverage$2,31156%
- Education$3408%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 3 | $1,319 |
| Kairos Surgical Inc | 4 | $775 |
| Stryker | 9 | $735 |
| Medical Device Business Services, Inc. | 9 | $549 |
| Acumed LLC | 7 | $475 |
| Arthrex | 2 | $258 |
| Bioventus LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AxoGuard Nerve Connector$1,319
- AxoGuard Nerve Protector$1,319
- T2$168
- VARIAX$156
- ASNIS$128
- ACUMED$116
- AVANCE NERVE GRAFT$102
How this compares
$4,129 in reported general payments places this provider in the 60th percentile of 68 hand surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 12 | $275 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $61 |
| Methylprednisolone | 15 | $59 |
| Cephalexin | 12 | $50 |
| Meloxicam | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Burlington
- Andrew JawaWaltham$2.6M
- George DyerBoston$362K
- Andrew PalmerProvincetown$264K
- Branden EarpBoston$74K
- Chaitanya MudgalBoston$46K
- Charles CassidyBoston$44K
- Bruce LeslieNewton$32K
- Peter ProkopisPeabody$27K
- Stella LeeNewburyport$21K
- Philip BlazarBoston$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.